Photo courtesy: The Indian Express
New Delhi: Countries like France, Italy and Belgium have asked the hospitals here to stop the use of anti-malaria drug Hydroxychloroquine to treat COVID-19 patients.
The medication was halted amid health safety of the infected patients.
The World Health Organization (WHO) also paused trials of the drug after a report published in the Lancet Journal claimed the medication was harming the patients.
Following the health body’s instructions, the three hardest-hit countries by the coronavirus cancelled the authorization of the drug.
Meanwhile, the countries will continue to carry out clinical trials of the drug outside human use. The trials will also expose the potential risks of using the drug and check its effectiveness in treating the virus.
Also Read: Anti-Malarial Drug Hydroxychloroquine Increases Risk Of Corona Deaths In US: Study
Cuttack: Pankaj Lochan Mohanty on Sunday assumed charge as president of Odisha Cricket Association (OCA). Mohanty,… Read More
Kolkata: The Railway Protection Force (RPF) of Eastern Railway (ER) claimed to have seized foreign… Read More
Bhubaneswar: Newly-appointed Odisha Congress president Bhakta Charan Das underwent a successful surgery for an injury… Read More
Bhubaneswar: Thunderstorm activity with lightning, gusty surface wind and hail may continue in Odisha till… Read More
Bhadrak: Police busted a sex racket operating from a hotel in Odisha's Bhadrak district late… Read More
New Delhi: Delhi Metro Rail Corporation (DMRC) claimed to have scaled the highest point till… Read More
This website uses cookies.
